Format

Send to

Choose Destination
J Travel Med. 2008 May-Jun;15(3):202-5. doi: 10.1111/j.1708-8305.2008.00209.x.

Yellow fever-associated viscerotropic disease in Barcelona, Spain.

Author information

1
Barcelona Centre for International Health Research (CRESIB), Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. jmunozg@clinic.ub.es

Abstract

Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for Wiley
Loading ...
Support Center